Sulfilatec, Inc. is a biotech company that is dedicated to helping patients with heart and kidney diseases. Heart disease is the leading cause of death among patients with kidney disease. Sulfilatec is discovering and developing new therapeutics for these patients.

Chris Cummings, PhD
President & Chief Executive Officer

All resident associate companies on the HudsonAlpha campus are independently owned and operated.